Prostatic artery embolization

Prostatic Artery Embolization (PAE) is a non-surgical treatment for benign prostatic hyperplasia (BPH), a condition that causes an enlarged prostate. This procedure is performed by an interventional radiologist and involves blocking the blood supply to the prostate to reduce its size.

Procedure

The Prostatic Artery Embolization procedure is performed under local anesthesia. The interventional radiologist makes a small incision in the groin or wrist to insert a catheter into the artery. Using X-ray guidance, the catheter is guided to the prostatic arteries that supply blood to the prostate. Small particles are then injected through the catheter into these arteries to block the blood flow, causing the prostate to shrink.

Benefits

Prostatic Artery Embolization is a minimally invasive procedure that can be performed on an outpatient basis. It has been shown to effectively reduce the symptoms of benign prostatic hyperplasia, including frequent urination, difficulty starting and stopping urination, and weak urine flow. It also has fewer side effects compared to traditional surgical treatments for BPH.

Risks

As with any medical procedure, there are risks associated with Prostatic Artery Embolization. These may include infection, bleeding, and damage to the arteries. There is also a small risk of impotence or urinary incontinence. However, these risks are generally lower than with surgical treatments for BPH.

Alternatives

Alternatives to Prostatic Artery Embolization include medications, lifestyle changes, and surgical treatments such as Transurethral Resection of the Prostate (TURP) and Prostatectomy.

See Also

• Benign Prostatic Hyperplasia
• Interventional Radiology
• Transurethral Resection of the Prostate
• Prostatectomy

Prostatic artery embolization Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.